BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20960248)

  • 1. Phosphonium reversible inhibitors of cholinesterases of different animals.
    Basova NE; Rozengart EV; Suvorov AA
    Dokl Biochem Biophys; 2010; 434():245-9. PubMed ID: 20960248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quaternary phosphonium reversibile inhibitors of cholinesterases of different animals].
    Basova NE; Rozengart EV; Suvorov AA
    Zh Evol Biokhim Fiziol; 2011; 47(5):358-64. PubMed ID: 22145316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium--oximes.
    Kuca K; Patocka J
    J Enzyme Inhib Med Chem; 2004 Feb; 19(1):39-43. PubMed ID: 15202491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterases.
    Kuca K; Cabal J; Jun D; Bajgar J; Hrabinova M
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):663-6. PubMed ID: 17252938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic bioscavengers against organophosphorus agents: mechanistic issues of self-reactivating cholinesterases.
    Lushchekina S; Masson P
    Toxicology; 2018 Nov; 409():91-102. PubMed ID: 30056174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin.
    Kuca K; Cabal J; Jun D; Hrabinova M
    Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of interactions of amodiaquine with human cholinesterases and organophosphorus compounds.
    Bierwisch A; Wille T; Thiermann H; Worek F
    Toxicol Lett; 2016 Mar; 246():49-56. PubMed ID: 26851641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation potency of new group of acetylcholinesterase reactivators and their comparison with currently available oximes.
    Kuca K; Pícha J; Jun D
    Acta Medica (Hradec Kralove); 2006; 49(4):233-5. PubMed ID: 17438836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 7. 1-Aryl-2-hydroxyiminomethyl-3-methylimidazolium iodides.
    Franchetti P; Grifantini M; Martelli S
    J Med Chem; 1974 Jan; 17(1):18-22. PubMed ID: 4808466
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myoneural conduction blockade by choline esters in the presence of cholinesterase inhibitors and restoration of conduction by cholinesterase reactivators].
    Protas LL
    Dokl Akad Nauk SSSR; 1973 Apr; 209(5):1243-6. PubMed ID: 4350639
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms underlying sensitivity to organophosphorus anticholinesterase compounds.
    Russell RW; Overstreet DH
    Prog Neurobiol; 1987; 28(2):97-129. PubMed ID: 2880369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of cholinesterase inhibitors and reactivators on the blocking action of dicarboxylic acid amino esters on neuromuscular conduction].
    Protas LL; Muske GA; Mndzhoian OL; Danilov AF; Mikhel'son MIa
    Farmakol Toksikol; 1975; 38(3):298-303. PubMed ID: 1227902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. V. Quaternary salts of hydroxyiminomethylimidazoles.
    Grifantini M; Martelli S; Stein ML
    J Pharm Sci; 1972 Apr; 61(4):631-3. PubMed ID: 5062578
    [No Abstract]   [Full Text] [Related]  

  • 14. [Structure-activity relationships in acetylcholinesterase reactivators inhibited by organophosphorus compounds. IV. N-hydroxyimidazole-3-oxides and their quaternary salts].
    Franchetti P; Grifantini M; Lucarelli C; Stein ML
    Farmaco Sci; 1972 Jan; 27(1):46-59. PubMed ID: 4353914
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central action of a new cholinesterase reactivator, diethyxime].
    Beznosko BK; Voronov IB; Feĭgman EE; Krivenchuk VE
    Farmakol Toksikol; 1977; 40(5):531-5. PubMed ID: 923773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cholinesterase activity: understanding and interpretation.
    Jokanović M; Maksimović M
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):11-6. PubMed ID: 9156559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sensitivity of the cholinesterase of the commander squid Berryteuthis magister to organophosphorus inhibitors of different structure.
    Rozengart EV; Basova NE; Suvorov AA
    Dokl Biochem Biophys; 2009; 427():206-11. PubMed ID: 19817138
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates.
    Jokanović M; Maksimović M; Kilibarda V; Jovanović D; Savić D
    Toxicol Lett; 1996 Apr; 85(1):35-9. PubMed ID: 8619258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of toxogonin to reactivate soman-inhibited brain acetylcholinesterase in monkeys and regeneration of the enzyme.
    Filbert MG; Fleisher JH; Lochner MA
    Biochim Biophys Acta; 1972 Sep; 284(1):164-74. PubMed ID: 4627450
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
    Jeong HC; Park NJ; Chae CH; Musilek K; Kassa J; Kuca K; Jung YS
    Bioorg Med Chem; 2009 Sep; 17(17):6213-7. PubMed ID: 19665386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.